Digestive Diseases and Sciences

, Volume 63, Issue 5, pp 1229–1236 | Cite as

Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer

  • Eun Mi Song
  • Jeong-Sik Byeon
  • Sun Mi Lee
  • Hyun Ju Yoo
  • Su Jung Kim
  • Sun-Ho Lee
  • Kiju Chang
  • Sung Wook Hwang
  • Dong-Hoon Yang
  • Jin-Yong Jeong
Original Article
  • 73 Downloads

Abstract

Background

The fatty acid profile of the fecal metabolome and its association with colorectal cancer (CRC) has not been fully evaluated.

Aims

We aimed to compare the fecal fatty acid profiles of CRC patients and healthy controls.

Methods

We enrolled 26 newly diagnosed CRC patients and 28 healthy individuals between July 2014 and August 2014 from our institute. Long- and short-chain fatty acids were extracted from fecal samples and analyzed using gas chromatography–mass spectrometry.

Results

Regarding fecal long-chain fatty acids, the levels of total ω-6 polyunsaturated fatty acids and, particularly, of linoleic acid (C18:2ω-6) were significantly higher in male CRC patients than in healthy men (2.750 ± 2.583 vs. 1.254 ± 0.966 µg/mg feces, P = 0.040; 2.670 ± 2.507 vs. 1.226 ± 0.940 µg/mg feces, P = 0.034, respectively). In addition, the levels of total monounsaturated fatty acid and, particularly, of oleic acid (C18:1ω-9) were significantly higher in male CRC patients than in healthy men (1.802 ± 1.331 vs. 0.977 ± 0.625 µg/mg feces, P = 0.027; 1.749 ± 1.320 vs. 0.932 ± 0.626 µg/mg feces, P = 0.011, respectively). However, those differences were not shown in female gender. The level of fecal short-chain fatty acids was not different between CRC patients and healthy controls.

Conclusions

There were changes in the profiles of fecal fatty acid metabolomes in CRC patients compared to healthy controls, implying that fecal fatty acids could be used as a novel screening tool for CRC.

Keywords

Colorectal neoplasm Feces Metabolome Fatty acids 

Notes

Author’s contribution

EMS, JSB, and JYJ designed the study; SML, HJY, SJK, SHL, KJC, SWH, and DHY collected, interpreted, and analyzed the data; EMS performed the statistical analysis; SHL, KJC, SWH, and DHY cared for the patients and critically reviewed the manuscript; EMS, JSB, and JYJ drafted the manuscript; and JSB and JYJ are the guarantors of the article and approved the final manuscript. All authors read and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

Eun Mi Song, Jeong-Sik Byeon, Sun Mi Lee, Hyun Ju Yoo, Su Jung Kim, Sun-Ho Lee, Kiju Chang, Sung Wook Hwang, Dong-Hoon Yang, and Jin-Yong Jeong have no conflict of interest or financial ties to declare.

Supplementary material

10620_2018_4982_MOESM1_ESM.docx (27 kb)
Supplementary material 1 (DOCX 26 kb)

References

  1. 1.
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMedGoogle Scholar
  2. 2.
    Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22:191–197.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bingham SA. Diet and colorectal cancer prevention. Biochem Soc Trans. 2000;28:12–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Park SY, Boushey CJ, Wilkens LR, Haiman CA, Le Marchand L. High-quality diets associate with reduced risk of colorectal cancer: analyses of diet quality indexes in the multiethnic cohort. Gastroenterology. 2017;153:386–394.CrossRefPubMedGoogle Scholar
  5. 5.
    Das S, Martinez LR, Ray S. Phospholipid remodeling and eicosanoid signaling in colon cancer cells. Indian J Biochem Biophys. 2014;51:512–519.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Bamia C, Lagiou P, Buckland G, et al. Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol. 2013;28:317–328.CrossRefPubMedGoogle Scholar
  7. 7.
    De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–14696.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Walker AW, Ince J, Duncan SH, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011;5:220–230.CrossRefPubMedGoogle Scholar
  9. 9.
    Xiao L, Sonne SB, Feng Q, et al. High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice. Microbiome. 2017;5:43.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol (N Y). 2013;9:560–569.Google Scholar
  11. 11.
    Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011;6:e16393.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299–306.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Jacob H, Toyonaga T, Ohara Y, et al. Endoscopic submucosal dissection of cecal lesions in proximity to the appendiceal orifice. Endoscopy. 2016;48:829–836.CrossRefPubMedGoogle Scholar
  14. 14.
    Wisniewski JR, Dus-Szachniewicz K, Ostasiewicz P, Ziolkowski P, Rakus D, Mann M. Absolute proteome analysis of colorectal mucosa, adenoma, and cancer reveals drastic changes in fatty acid metabolism and plasma membrane transporters. J Proteome Res. 2015;14:4005–4018.CrossRefPubMedGoogle Scholar
  15. 15.
    Jacobs DM, Deltimple N, van Velzen E, et al. (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 2008;21:615–626.CrossRefPubMedGoogle Scholar
  16. 16.
    Matsumoto M, Benno Y. Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutat Res. 2004;568:147–153.CrossRefPubMedGoogle Scholar
  17. 17.
    Awad AB, Chattopadhyay JP, Danahy ME. Effect of dietary fat composition on rat colon plasma membranes and fecal lipids. J Nutr. 1989;119:1376–1382.CrossRefPubMedGoogle Scholar
  18. 18.
    Park Y, Lee J, Oh JH, Shin A, Kim J. Dietary patterns and colorectal cancer risk in a Korean population: a case-control study. Medicine (Baltimore). 2016;95:e3759.CrossRefGoogle Scholar
  19. 19.
    Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.PubMedGoogle Scholar
  20. 20.
    Pickens CA, Albuquerque Pereira MF, Fenton JI. Long-chain omega-6 plasma phospholipid polyunsaturated fatty acids and association with colon adenomas in adult men: a cross-sectional study. Eur J Cancer Prev. 2017;26:497–505.CrossRefPubMedGoogle Scholar
  21. 21.
    McEntee MF, Whelan J. Dietary polyunsaturated fatty acids and colorectal neoplasia. Biomed Pharmacother. 2002;56:380–387.CrossRefPubMedGoogle Scholar
  22. 22.
    Hodge AM, Williamson EJ, Bassett JK, MacInnis RJ, Giles GG, English DR. Dietary and biomarker estimates of fatty acids and risk of colorectal cancer. Int J Cancer. 2015;137:1224–1234.CrossRefPubMedGoogle Scholar
  23. 23.
    Weijenberg MP, Luchtenborg M, de Goeij AF, et al. Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes. Cancer Causes Control. 2007;18:865–879.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Cottet V, Collin M, Gross AS, et al. Erythrocyte membrane phospholipid fatty acid concentrations and risk of colorectal adenomas: a case-control nested in the French E3 N-EPIC cohort study. Cancer Epidemiol Biomarkers Prev. 2013;22:1417–1427.CrossRefPubMedGoogle Scholar
  25. 25.
    Macquart-Moulin G, Riboli E, Cornee J, Charnay B, Berthezene P, Day N. Case-control study on colorectal cancer and diet in Marseilles. Int J Cancer. 1986;38:183–191.CrossRefPubMedGoogle Scholar
  26. 26.
    Bartoli R, Fernandez-Banares F, Navarro E, et al. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut. 2000;46:191–199.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Audano M, Maldini M, De Fabiani E, Mitro N, Caruso D. Gender-related metabolomics and lipidomics: from experimental animal models to clinical evidence. J Proteomics. 2017.  https://doi.org/10.1016/j.jprot.2017.11.001.PubMedGoogle Scholar
  28. 28.
    Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET. Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008;21:195–207.CrossRefPubMedGoogle Scholar
  29. 29.
    Krumsiek J, Mittelstrass K, Do KT, et al. Gender-specific pathway differences in the human serum metabolome. Metabolomics. 2015;11:1815–1833.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Jove M, Mate I, Naudi A, et al. Human aging is a metabolome-related matter of gender. J Gerontol A Biol Sci Med Sci. 2016;71:578–585.CrossRefPubMedGoogle Scholar
  31. 31.
    Gonzalez-Covarrubias V, Beekman M, Uh HW, et al. Lipidomics of familial longevity. Aging Cell. 2013;12:426–434.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Farshidfar F, Weljie AM, Kopciuk KA, et al. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics. Br J Cancer. 2016;115:848–857.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Xie G, Wang X, Zhao A, et al. Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. Sci Rep. 2017;7:45232.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ridlon JM, Ikegawa S, Alves JM, et al. Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens. J Lipid Res. 2013;54:2437–2449.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013;8:e70803.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Bornet FR, Brouns F, Tashiro Y, Duvillier V. Nutritional aspects of short-chain fructooligosaccharides: natural occurrence, chemistry, physiology and health implications. Dig Liver Dis. 2002;34:S111–S120.CrossRefPubMedGoogle Scholar
  37. 37.
    Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235–243.CrossRefPubMedGoogle Scholar
  38. 38.
    Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6:320–329.CrossRefPubMedGoogle Scholar
  39. 39.
    Deda O, Gika H, Panagoulis T, Taitzoglou I, Raikos N, Theodoridis G. Impact of exercise on fecal and cecal metabolome over aging: a longitudinal study in rats. Bioanalysis. 2017;9:21–36.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulKorea
  2. 2.Department of Convergence Medicine, Asan Medical Center, Asan Institute for Life SciencesUniversity of Ulsan College of MedicineSeoulKorea

Personalised recommendations